February 1, 2025 - 10:32

The United States is currently investigating DeepSeek regarding its potential procurement of Nvidia chips through a third party based in Singapore. This inquiry raises questions about the compliance of the company's supply chain practices, particularly in light of ongoing concerns over technology transfers and national security.
Meanwhile, Apple remains optimistic about its business outlook, even as it confronts challenges in the Chinese market. The tech giant's resilience is evident as it navigates a complex landscape marked by fluctuating demand and competitive pressures.
In related news, HPE is facing hurdles in its $14 billion acquisition of Juniper Networks. The deal has encountered scrutiny from the US Department of Justice, which may impact the timeline and structure of the acquisition. HPE CEO Antonio Neri has been vocal about the strategic importance of this acquisition for the company's growth and innovation plans.
As these developments unfold, the tech industry remains on high alert, balancing growth ambitions with regulatory challenges.
June 21, 2026 - 01:52
Mankind must not sacrifice human dignity at the altar of AISome ways of talking about human beings are always out of bounds. Sorting people by economic value into those who merit work and those who should be sidelined is one of them, and any society that...
June 20, 2026 - 18:23
Is Marvell Technology Going to $1 Trillion?Nvidia`s chief executive recently made a bold prediction about Marvell Technology, suggesting the chipmaker could one day join the trillion-dollar club. The comment sparked fresh interest in a...
June 19, 2026 - 18:29
A Tech Twist for Father's Day: New App Brings Old Photos to LifeForget the usual tie or toolbox this Father`s Day. A new mobile application is offering a different kind of gift: the chance to see faded memories with fresh eyes. The app uses simple artificial...
June 19, 2026 - 00:54
FDA panel backs first-of-its-kind flu vaccine using mRNA technologyA new kind of flu vaccine moved a step closer to the U.S. market Thursday. An advisory panel for the Food and Drug Administration voted overwhelmingly in favor of approving the first influenza shot...